Cell Genesys’ GVAX - The Most Promising Cancer Vaccine

Monday, May 7th, 2007

With all the fervor around Dendreon’s (DNDN) Provenge there is renewed interest in cancer vaccines, a therapeutic approach which deals with stimulating the body’s immune system to attack tumors. (more…)